Connect with us

CoronaVirus

Moderna Begins Phase 2/3 of Vaccinations for Children

Published

on

Moderna has begun distributing their three-part vaccine to children ages 6 months to 12 years old, called the KidCOVE study. They are currently in phase 2, distributing the vaccine to children 6 months to 12 years old and younger, stated in a report published on Moderna’s website.

Stéphane Bancel, Chief Executive Officer of Moderna, stated they will begin testing the vaccine on healthy children in the United States and in Canada.

During Phase 2, Moderna will be monitoring the safety and effectiveness, along with other protocols in children who have already received the vaccine. After the first dose, children will be given the second dose 28 days later and will be monitored during a 12-month span. In Phase 3, the vaccine will be given to ages 18 years and older. For more information regarding the KidCOVE study, you can visit the Moderna website here: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-first-participants-dosed-phase-23-study-0.

For general information on Moderna’s vaccine, you can visit their home page at https://www.modernatx.com. 

Victoria Turrentine was born and raised in Prince George's County. Graduating from Washington Adventist University with a B.A. in Print Journalism, she followed her passion and became a writer for The DMV Daily. She continues her love for writing through screenwriting and storytelling.

Continue Reading
Days :
Hours :
Minutes

Unity Day 2024 is for the community and gives the youth an opportunity to be kids. Come meet some celebrities, ball players, race stars and more 🎪

 

 

Join our Unity Day Raffle to win some of our cool gifts we are giving away at the event. Click here to learn about the Raffle.